Drug Shortage Report for TEGRETOL CR

Last updated on 2024-07-16 History
Report ID 227209
Drug Identification Number 00755583
Brand name TEGRETOL CR
Common or Proper name TEGRETOL CR 400MG TABS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100'S
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-05-07
Actual start date 2024-05-07
Estimated end date 2024-07-22
Actual end date
Shortage status Actual shortage
Updated date 2024-07-16
Company comments Product is on allocation to minimize patient impact.
Health Canada comments
Tier 3 Status Yes
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-07-16 French Compare
v9 2024-07-16 English Compare
v8 2024-07-09 French Compare
v7 2024-07-09 English Compare
v6 2024-06-19 French Compare
v5 2024-06-19 English Compare
v4 2024-05-13 English Compare
v3 2024-05-08 English Compare
v2 2024-05-07 French Compare
v1 2024-05-07 English Compare

Showing 1 to 10 of 10